Trace elements profile in the blood of Huntington' disease patients

Stefania Squadrone1, Paola Brizio1, Maria Cesarina Abete1

  • 1Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta, via Bologna 148, 10154 Torino, Italy.

Insights

Huntington's disease (HD) patients show altered blood metal levels. Increased iron, chromium, selenium, zinc, and arsenic may offer new diagnostic and therapeutic targets for this neurodegenerative disorder.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Genetics

Background:

  • Huntington's disease (HD) is a neurodegenerative disorder characterized by motor, psychiatric, and cognitive decline.
  • HD is linked to polyglutamine expansion in proteins, leading to aberrant folding.
  • Metal accumulation can cause protein misfolding and oxidative stress, potentially contributing to neurodegeneration.

Purpose of the Study:

  • To investigate blood concentrations of essential and nonessential trace elements in HD patients.
  • To determine if metal homeostasis alterations are associated with HD pathogenesis.

Main Methods:

  • Analysis of blood samples from HD patients.
  • Quantification of essential trace elements (Cr, Co, Cu, Fe, Mn, Mo, Ni, Se, Zn).
  • Quantification of nonessential trace elements (As, Cd, Sb, Sn, V).

Main Results:

  • Elevated levels of essential elements: iron, chromium, selenium, and zinc in HD patients.
  • Increased levels of the nonessential element arsenic in HD patients.
  • Significant differences in blood metal profiles between HD patients and controls.

Conclusions:

  • Alterations in metal homeostasis may play a role in the pathogenesis of Huntington's disease.
  • Blood metal profiles could serve as a potential in vivo diagnostic and characterization tool for HD.
  • Further research into metal dysregulation in HD may reveal novel therapeutic strategies.